These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6124583)

  • 41. New detection of brain dopamine receptors with (3H)dihydroergocryptine.
    Tittler M; Weinreich P; Seeman P
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3750-3. PubMed ID: 410026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective reduction of one class of dopamine receptor binding sites in the corpus striatum of aged rats.
    De Blasi A; Mennini T
    Brain Res; 1982 Jun; 242(2):361-4. PubMed ID: 7116143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of effects of fibrinogen degradation products on specific binding of [3H]spiroperidol and [3H]ADTN.
    Buczko W; De Blasi A
    Pol J Pharmacol Pharm; 1983; 35(1):45-7. PubMed ID: 6889186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and dopaminergic activity of some halogenated mono- and dihydroxylated 2-aminotetralins.
    Weinstock J; Gaitanopoulos DE; Oh HJ; Pfeiffer FR; Karash CB; Venslavsky JW; Sarau HM; Flaim KE; Hieble JP; Kaiser C
    J Med Chem; 1986 Sep; 29(9):1615-27. PubMed ID: 2875183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the binding of [3H]spiperone and [3H]domperidone in homogenates of mammalian retina and caudate nucleus.
    Watling KJ; Iversen LL
    J Neurochem; 1981 Nov; 37(5):1130-43. PubMed ID: 7299392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Guanine nucleotides do not inhibit tritiated dopamine agonist binding to bovine striatal membranes.
    Near JA; Mahler HR
    Neurochem Res; 1982 Jul; 7(7):831-7. PubMed ID: 7121724
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Irreversible binding of [3H](-)N-chloroethylnorapomorphine to mammalian brain tissue.
    Baldessarini RJ; Kula NS
    Life Sci; 1983 Aug; 33(8):769-78. PubMed ID: 6193387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics.
    Richfield EK
    Brain Res; 1991 Feb; 540(1-2):1-13. PubMed ID: 1829013
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Binding of [3H]SCH23390 in rat brain: regional distribution and effects of assay conditions and GTP suggest interactions at a D1-like dopamine receptor.
    Schulz DW; Stanford EJ; Wyrick SW; Mailman RB
    J Neurochem; 1985 Nov; 45(5):1601-11. PubMed ID: 2864398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopamine receptors in canine caudate nucleus.
    Maeno H
    Mol Cell Biochem; 1982 Mar; 43(2):65-80. PubMed ID: 6123940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 6,7-Dihydroxy-3-chromanamine: synthesis and pharmacological activity of an oxygen isostere of the dopamine agonist 6,7-dihydroxy-2-aminotetralin.
    Horn AS; Kaptein B; Mulder TB; de Vries JB; Wynberg H
    J Med Chem; 1984 Oct; 27(10):1340-3. PubMed ID: 6090664
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [3H]Fluphenazine binding to brain membranes: simultaneous measurement of D-1 and D-2 receptor sites.
    Morgan DG; Finch CE
    J Neurochem; 1986 May; 46(5):1623-31. PubMed ID: 2937884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
    Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
    Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization with 3H-haloperidol of the dopamine receptor in the rat kidney particulate preparation.
    Nakajima T; Kuruma I
    Jpn J Pharmacol; 1980 Dec; 30(6):891-8. PubMed ID: 6113299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Further in vitro and in vivo studies with the putative presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin.
    Mulder TB; de Vries JB; Dijkstra D; Wiechers JW; Grol CJ; Horn AS
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):494-501. PubMed ID: 2830544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dopaminergic binding sites in rat striatal slices and the action of guanyl nucleotides.
    Martres MP; Sokoloff P; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):116-23. PubMed ID: 6717609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE; Gommeren W
    J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Binding of [3H]amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat striatal membranes. Effects of purine nucleotides and ultraviolet irradiation.
    Zahniser NR; Heidenreich KA; Molinoff PB
    Mol Pharmacol; 1981 May; 19(3):372-8. PubMed ID: 7266464
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
    Faedda G; Kula NS; Baldessarini RJ
    Biochem Pharmacol; 1989 Feb; 38(3):473-80. PubMed ID: 2563653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.